User login
Dr. David Henry takes you on an audio tour of the June issue, including reviews of ruxolitinib for myelofibrosis, advances in the treatment of medullary thyroid cancer, and biosimilars. Also, original research on recurrence and survival in early-stage triple-negative breast cancer.
Dr. David Henry takes you on an audio tour of the June issue, including reviews of ruxolitinib for myelofibrosis, advances in the treatment of medullary thyroid cancer, and biosimilars. Also, original research on recurrence and survival in early-stage triple-negative breast cancer.
Dr. David Henry takes you on an audio tour of the June issue, including reviews of ruxolitinib for myelofibrosis, advances in the treatment of medullary thyroid cancer, and biosimilars. Also, original research on recurrence and survival in early-stage triple-negative breast cancer.